Applied Molecular Transport Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Shawn Cross
Amministratore delegato
US$1.7m
Compenso totale
| Percentuale dello stipendio del CEO | 27.7% |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.2% |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | 2.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Mar 07
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Nov 13Applied Molecular Transport GAAP EPS of -$0.93
Aug 04Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky
Jul 27Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data
Jul 05Applied Molecular: Interesting Drug Delivery Approach For The GI Tract
May 03We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Apr 28We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Jan 08We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Aug 29Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans
Apr 05Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?
Feb 11Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Dec 21Applied Molecular Transport reports Q3 results
Nov 12Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$75m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$112m |
| Dec 31 2022 | US$2m | US$476k | -US$126m |
| Sep 30 2022 | n/a | n/a | -US$134m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$122m |
| Dec 31 2021 | US$3m | US$410k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$89m |
| Jun 30 2021 | n/a | n/a | -US$80m |
| Mar 31 2021 | n/a | n/a | -US$72m |
| Dec 31 2020 | US$2m | US$311k | -US$67m |
Compensazione vs Mercato: La retribuzione totale di Shawn ($USD 1.72M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 649.07K ).
Compensazione vs guadagni: La retribuzione di Shawn è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Shawn Cross (55 yo)
less than a year
Mandato
US$1,717,813
Compensazione
Mr. Shawn M. Cross serves as Managing Director of Healthcare Investment Banking Group at Citizens JMP Securities, LLC (formerly known as JMP Securities LLC). He was Managing Director and Co-Head Healthcare...
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$1.72m | 0.17% $ 18.3k | |
| Co-Founder & Director | 7.1yrs | US$3.55m | 9.77% $ 1.1m | |
| Independent Director | 1.8yrs | US$394.26k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 1.9yrs | US$429.94k | 0% $ 0 | |
| Independent Director | 7.1yrs | US$90.28k | 0.51% $ 55.9k | |
| Lead Independent Director | 2.3yrs | US$102.84k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
2.1yrs
Durata media
57yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di AMTI non è considerato esperto (durata media del mandato 2.1 anni), il che suggerisce un nuovo consiglio.